Home » Topics » Regulatory » Patents

Patents
RSS

PharmaGenics discloses oligonucleotides

June 7, 1996

Searle discloses LTA4 hydrolase inhibitors

June 7, 1996

Ciba-Geigy discloses glycine-site NMDA antagonists

June 7, 1996

BASF reports glutamate receptor antagonists

June 7, 1996

ADIR reports piperazines with affinity for sigma-receptors

June 7, 1996

Cytokine polypeptides described by Immunex

June 7, 1996

Pfizer reports neuroleptics

June 7, 1996

Asahi Chem. claims sigma-receptor ligands

June 7, 1996

Compounds with high affinity for 5-HT1A and/or D2 receptors reported by E. Merck

June 7, 1996

Bristol-Myers Squibb describes compounds with melatonergic properties

June 7, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...